A carregar...
Extended interval dosing of natalizumab: a two-center, 7-year experience
BACKGROUND: The enthusiasm for natalizumab, a highly efficacious agent in the treatment of multiple sclerosis (MS), has been tempered by the risks of progressive multifocal leukoencephalopathy associated with its use, and strategies to minimize those risks are of great interest. Extended interval do...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4206618/ https://ncbi.nlm.nih.gov/pubmed/25342976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285614540224 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|